MindWalk (NASDAQ:HYFT) Rating Increased to Strong-Buy at JonesTrading

JonesTrading upgraded shares of MindWalk (NASDAQ:HYFT) to a strong-buy rating in a research report sent to investors on Wednesday morning,Zacks.com reports.

Several other analysts have also recently issued reports on HYFT. HC Wainwright reaffirmed a “buy” rating on shares of MindWalk in a report on Friday, March 13th. Zacks Research raised shares of MindWalk from a “strong sell” rating to a “hold” rating in a report on Monday, February 16th. UBS Group reaffirmed a “buy” rating on shares of MindWalk in a report on Friday, March 13th. Finally, Weiss Ratings started coverage on shares of MindWalk in a report on Wednesday, January 14th. They issued a “sell (d-)” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $5.00.

MindWalk Trading Up 3.4%

NASDAQ HYFT opened at $1.37 on Wednesday. The stock’s fifty day moving average price is $1.23. MindWalk has a 52 week low of $0.40 and a 52 week high of $3.25. The company has a current ratio of 3.74, a quick ratio of 3.64 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $63.01 million, a PE ratio of -6.83 and a beta of 0.63.

MindWalk (NASDAQ:HYFT) last posted its earnings results on Thursday, March 12th. The company reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.02). MindWalk had a negative return on equity of 69.37% and a negative net margin of 66.79%.The firm had revenue of $3.00 million for the quarter, compared to analyst estimates of $3.50 million.

Institutional Trading of MindWalk

A number of institutional investors and hedge funds have recently modified their holdings of HYFT. Jane Street Group LLC raised its holdings in shares of MindWalk by 147.3% during the fourth quarter. Jane Street Group LLC now owns 161,202 shares of the company’s stock worth $293,000 after purchasing an additional 96,018 shares during the period. Bridgeway Capital Management LLC acquired a new stake in shares of MindWalk during the fourth quarter worth $91,000. XTX Topco Ltd raised its holdings in shares of MindWalk by 118.6% during the fourth quarter. XTX Topco Ltd now owns 81,721 shares of the company’s stock worth $149,000 after purchasing an additional 44,331 shares during the period. Virtu Financial LLC acquired a new stake in shares of MindWalk during the fourth quarter worth $51,000. Finally, Bank of Montreal Can raised its holdings in shares of MindWalk by 81.0% during the fourth quarter. Bank of Montreal Can now owns 54,750 shares of the company’s stock worth $100,000 after purchasing an additional 24,500 shares during the period. 6.70% of the stock is owned by institutional investors and hedge funds.

MindWalk Company Profile

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation.